Skip to search formSkip to main contentSkip to account menu

antineoplaston AS 2-1

Known as: L-Glutamine, N2-(phenylacetyl)-, Monosodium Salt, Mixture with Sodium Benzeneacetate, AS2-1 antineoplaston, antineoplaston AS21 
A 4:1 mixture of phenylacetate and phenylacetylgluatmine, degradation products of the antineoplaston agent A10. Antineoplaston AS2-1 inhibits the… 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (3)

Drug CombinationsGlutaminePhenylacetates
NCIt Antineoplastic Agent Terminologyanalogs & derivatives

Narrower (1)

NSC 620261

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Epilepsy Is Associated With Dysregulation of Long Non-coding RNAs in the Peripheral Blood
Background: Long non-coding RNAs (lncRNAs) are a group of functional transcripts that are not translated to proteins. Recent… 
2019
2019
LncRNA HIF1A-AS2 promotes osteosarcoma progression by acting as a sponge of miR-129-5p
Increasing studies have demonstrated that long noncoding RNAs (lncRNAs) play vital roles in tumor development and progression… 
2018
2018
Long noncoding RNA HOXD‐AS2 regulates cell cycle to promote glioma progression
Now, numerous exciting findings have been found that long noncoding RNAs (lncRNAs) play a vital role in cancer malignant… 
Highly Cited
2017
Highly Cited
2017
A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers
Background: Triple-negative breast cancer (TNBC) is an aggressive cancer with unfavorable outcome and it is useful to explore… 
2016
2016
The long non-coding RNA EPB41L4A-AS2 inhibits tumor proliferation and is associated with favorable prognoses in breast cancer and other solid tumors
EPB41L4A-AS2 is a novel long non-coding RNA of unknown function. In this study, we investigated the expression of EPB41L4A-AS2 in… 
1991
1991
Interferon in combination with antitumourigenic phenyl derivatives: potentiation of IFNα activity in‐vitro
Any attempt to eradicate the heterogeneous cell population of a tumour mass would require the use of appropriate combination… 
1990
1990
Treatment of hormonally refractory cancer of the prostate with antineoplaston AS2-1.
Successful treatment of advanced cancer of the prostate which no longer responds to hormonal manipulation continues to be a… 
Review
1986
Review
1986
Antineoplastons: history of the research (I).
Antineoplastons are naturally-occurring peptides and amino acid derivatives which control neoplastic growth. The theory of… 
1986
1986
Preclinical studies on antineoplaston AS2-1 and antineoplaston AS2-5.
Antineoplaston AS2-1 and Antineoplaston AS2-5 are degradation products of Antineoplaston A10. The initial hydrolysis of… 
1974
1974
PASSIVE ENHANCEMENT OF RAT RENAL ALLOGRAFTS WITH ONLY PARTIAL COVER OF THE INCOMPATIBLE Ag‐B SPECIFICITIES
DA anti-Lewis and DA anti-AS2 sera have little or no specificity when tested for passive enhancement of rat renal allografts. The… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)